Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced the closing of its underwritten registered public offering of 5,366 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback